In Silico Analysis of Mutated SARS-CoV-2 N Protein of Java Origin and Human IgG Antibody as a Potential Vaccine Candidate
The high mutation rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) may alter viral protein structures and reduce the effectiveness of vaccines that primarily target the spike (S) protein. The nucleocapsid (N) protein is highly conserved and immunogenic, making it a promising alternative antigen for...